TBIO News

Codex DNA, which makes an automated synthetic biology workstation and related solutions, raised $107 million by offering 6.7 million shares at $16, the high end of the range of $14 to $16. Codex DNA states that its synthetic biology solution addresses the bottlenecks across the multi-step process of building DNA and mRNA. A key part of its solution is its BioXp system, an...read more

Codex DNA, which makes an automated synthetic biology workstation and related solutions, announced terms for its IPO on Monday. The San Diego, CA-based company plans to raise $100 million by offering 6.7 million shares at a price range of $14 to $16. At the midpoint of the proposed range, Codex DNA would command a fully diluted market value of $448 million. Codex DNA...read more

Codex DNA, which makes an automated synthetic biology workstation and related solutions, filed on Friday with the SEC to raise up to $100 million in an initial public offering. Codex DNA states that its synthetic biology solution addresses the bottlenecks across the multi-step process of building DNA and mRNA. A key part of its solution is its BioXp system, an end-to-end...read more

12 IPOs raised $2.3 billion in the IPO market's busiest week of the year. June 2018 also the set a record as the most active month for IPOs in three years. And as IPO Pro subscribers can see in our newly-released ...read more